Joe Spector | Founder & CEO, Dutch
Joe Spector immigrated to the U.S. as a child refugee from Uzbekistan, went on to build Hims into a multi-billion-dollar public company, and is now applying the telehealth playbook to pets with Dutch. In this combined interview, he unpacks the realities of building at massive scale, spending $10M/month on marketing, navigating regulation, raising hundreds of millions in capital, and why pet telemedicine is still in its earliest innings.
This week we speak with Joe Spector, the founder & CEO of Dutch and Hims. Joe’s journey — immigrating to the U.S. as a child from Uzbekistan, building a multi-billion-dollar public company, and now tackling pet telehealth — is nothing short of incredible.
This interview combines both parts of our conversation, covering Joe’s early life, the rise of Hims, and his current work building Dutch at the intersection of veterinary care, regulation, and technology.
You immigrated from Uzbekistan to the US when you were 10 years old. Why did you have to flee Uzbekistan and what was your experience like when you reached the US?
My parents and I fled Uzbekistan because we’re Jewish and we were facing mounting anti-Semitism, which is unfortunately a story as old as time for Jews wherever they live. Specifically, anti-Semitism meant losing a job, college admissions rejections, and housing discrimination just to name a few.
In the US, our initial label was “legal aliens” and we certainly felt that way. Everything was foreign and every experience was new. We lived on welfare and in subsidized housing. My highly educated dad had to work for cash at a flea market doing manual labor. I was called a communist by the playground kids. Good thing I couldn’t understand most of what they said since I didn’t know any English. The experiences during those years have taught me resilience and survival. I have seen what it’s like to lose everything and rebuild again and again.
Other Interviews
More conversations with founders, operators, and investors building the future of pet care.
Alexandru Bacita | Co-Founder & COO, The Cat Health Company
Cats are living longer, but the drugs for age-related disease have not kept pace. The Cat Health Company, a clinical-stage biotech, has three drugs in trials and 11 more preclinical candidates, and has out-licensed its first therapeutic. Co-founder and COO Alexandru Bacita explains why cats compress the drug-development loop, how the company targets muscle loss and kidney disease first, and why the route to longevity runs through veterinarians and pharma partners.
Elias Weiss Friedman | Founder, The Dogist Company
Elias Weiss Friedman spent a decade turning street photography into The Dogist, one of the largest dog-focused audiences online. Now he's testing whether that trust extends to physical products, starting with Vitality, a vet-formulated antioxidant chew built with Dr. Angela Rollins. He talks about the discipline of brand extension, the operational learning curve of a first physical product, and what a decade of stopping strangers on the street taught him about people, not just dogs.
Sarah McLean | Co-Founder & CEO, Big Damn Dog Co.
A joint supplement label that stopped at 60 pounds sent Sarah McLean looking for a product that did not exist. Big Damn Dog Co. is the bootstrapped answer: giant-breed formulations, dosing built for 120-pound dogs, and a customer list the founders still call by phone. Six months after launch, its Gravy Blend already accounts for roughly 40% of joint supplement sales.